1.Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.
Harshal Surendra MANDAVDHARE ; Vishal SHARMA ; Kaushal K PRASAD ; Amit KUMAR ; Manish RATHI ; Surinder S RANA
Intestinal Research 2017;15(3):419-421
Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.
Angiotensin Receptor Antagonists*
;
Angiotensins*
;
Atrophy
;
Celiac Disease
;
Diarrhea
;
Duodenum
;
Endoscopy
;
Female
;
Humans
;
Hypertension
;
Hypothyroidism
;
Middle Aged
;
Olmesartan Medoxomil
;
Pectinidae
;
Renal Insufficiency, Chronic
;
Upper Gastrointestinal Tract
;
Valsartan
;
Weight Loss
2.Natural products: a safest approach for obesity.
Neeru VASUDEVA ; Neerja YADAV ; Surendra Kumar SHARMA
Chinese journal of integrative medicine 2012;18(6):473-480
Obesity is recognized as a social problem, associated with serious health risks and increased mortality. Numerous trials have been conducted to find and develop new anti-obesity drugs through herbal sources to minimize adverse reactions associated with the present anti-obesity drugs. The use of natural products as medicine has been documented for hundreds of years in various traditional systems of medicines throughout the world. This review focuses on the medicinal plants such as Achyranthus aspera, Camellia sinensis, Emblica officinalis, Garcinia cambogia, Terminalia arjuna, etc., being used traditionally in Ayurvedic, Unani, Siddha and Chinese, etc., systems of medicine. The review also highlights recent reported phytochemicals such as escins, perennisosides, dioscin, gracillin, etc., and the various extracts of the plants like Nelumbo nucifera, Panax japonicas, Cichorium intybus, Cyperus rotundus, Paeonia suffruticosa, etc., which have been successfully identified for the treatment of obesity.
Anti-Obesity Agents
;
adverse effects
;
therapeutic use
;
Biological Products
;
adverse effects
;
therapeutic use
;
Complementary Therapies
;
Humans
;
Obesity
;
drug therapy
;
Plant Extracts
;
adverse effects
;
therapeutic use
;
Plants, Medicinal
;
chemistry